Deutsche Bank’s ACELYRIN SLRN Stock Holding History

Deutsche Bank’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-61,539	Closed	-$152K	–	3722
2025 Q1	$152K	Sell	61,539 -8,461	-12%	-$20.1K	﹤0.01%	3070
2024 Q4	$220K	Buy	70,000 +24,356	+53%	+$118K	﹤0.01%	3057
2024 Q3	$225K	Buy	45,644 +12,570	+38%	+$64.9K	﹤0.01%	2874
2024 Q2	$146K	Sell	33,074 -205	-0.6%	-$961	﹤0.01%	2975
2024 Q1	$225K	Buy	33,279 +18,763	+129%	+$143K	﹤0.01%	2766
2023 Q4	$108K	Sell	14,516 -819	-5%	-$6.99K	﹤0.01%	3187
2023 Q3	$156K	Buy	+15,335	New	+$326K	﹤0.01%	2929

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deutsche Bank's SLRN Position: Q2 2025 in Review

Deutsche Bank sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 61,539 shares — an estimated $152K sold.

Deutsche Bank first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $225K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Deutsche Bank reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Deutsche Bank sold 61,539 ACELYRIN shares in Q2 2025, an estimated $152K.
Deutsche Bank first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
Deutsche Bank's ACELYRIN position peaked at $225K in Q3 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.